Discover investment opportunities in AI Medical Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Medical Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Medical Stocks using our Smart AI Filter.
10 stocks found for "AI Medical Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.50 | ±64.8% | -8.0 | 0.00% | |||
1.02 | ±49.1% | 40.9 | 0.00% | |||
0.36 | ±21.7% | 15.1 | 3.17% | |||
0.64 | ±28.2% | 69.3 | 0.00% | |||
0.89 | ±41.9% | 22.8 | 0.00% | |||
1.15 | ±39.9% | 36.1 | 0.00% | |||
1.77 | ±71.4% | -18.6 | 0.00% | |||
1.19 | ±53.7% | -156.9 | 0.00% | |||
1.92 | ±85.0% | -11.8 | 0.00% | |||
1.06 | ±40.4% | 66.4 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How has Intuitive Surgical (ISRG) performed historically in terms of growth?
A: Historically, Intuitive Surgical (ISRG) has been a leader in robotic-assisted surgery, showing consistent revenue growth. The company's pioneering role in minimally invasive surgeries and continuous innovation positions it well for long-term expansion. However, investors should consider the high valuation and potential regulatory challenges.
Q: Does Teladoc Health (TDOC) offer potential for income through dividends?
A: Teladoc Health (TDOC) does not currently offer dividends. As a growth-oriented company focused on telehealth services, TDOC typically reinvests earnings into business expansion and technological advancements instead of paying shareholder dividends.
Q: How might Illumina (ILMN) be impacted by changes in regulatory policies?
A: As a leader in sequencing and genomics, Illumina (ILMN) operates in a sector sensitive to regulatory shifts due to its focus on genetics and diagnostics. Stricter regulations may affect its R&D costs and global sales, but innovation and adaptability remain key strengths.
Q: What role does GE HealthCare Technologies (GEHC) play in the AI medical sector?
A: GE HealthCare Technologies (GEHC) is significant in the AI medical sector through its advanced imaging and patient monitoring solutions. By incorporating AI, GEHC enhances diagnostic accuracy and operational efficiency, which may offer competitive advantages amid growing demand for tech-driven healthcare solutions.
Q: Why is QIAGEN (QDEL) considered important for diagnostic advancements?
A: Qiagen, often listed under the ticker QDEL, specializes in molecular diagnostics and sample preparation technologies. Its broad portfolio supports innovative diagnostic solutions, aligning with growing needs for precise testing in both clinical and research settings, which is critical for personalized medicine.
Q: How does Guardant Health (GH) contribute to cancer diagnostics?
A: Guardant Health (GH) plays a pivotal role in cancer diagnostics by focusing on liquid biopsies. Their technology allows for less invasive monitoring and early detection of cancer, potentially transforming cancer treatment and improving patient outcomes by providing real-time insights.